30-day average of 21 articles · scale −100 to +100
Across 21 scored articles from Oct 16 to Nov 14, 2026 (UTC),
the average sentiment of MetLife news is Somewhat Bullish (+40)
on a scale from −100 to +100.
That is about the same as the previous 30 days (+44).
💸 The company returned approximately $1 billion to shareholders via buybacks and dividends in Q3.
🏦 Net income surged 187% year-over-year to $2.4 billion, or $3.67 per share.
🎯 MetLife remains on track to meet its full-year free cash flow and direct expense ratio targets.
💼 CEO Michel Khalaf reaffirmed confidence in the New Frontier strategy and execution discipline.
📉 Holding-company cash and liquid assets stood at $3.4 billion, within management's target range.
🚀 Broad-based operating momentum supports the case for resilient earnings across divisions.
📈 Bullish signals
📈MetLife reported record Q3 adjusted EPS of $2.85 excluding notable items, a 22% increase from the prior-year quarter and the highest in company history.
💰Revenue increased 12% to $14.1 billion with growth spanning all six business segments, demonstrating broad-based momentum.
📊Adjusted return on equity reached 19.6% excluding notable items, reflecting strong capital efficiency.
💸The company returned approximately $1 billion to shareholders through buybacks and dividends, signaling confidence in its financial position.
🏦Net income surged 187% year-over-year to $2.4 billion, driven by higher variable investment income and favorable underwriting.
🎯MetLife remains on track to meet its full-year free cash flow and direct expense ratio targets, ensuring disciplined capital management.
💼CEO Michel Khalaf reaffirmed confidence in the New Frontier strategy, citing stronger underwriting and volume growth as key drivers.
Article
MetLife Inc. reported record third-quarter adjusted earnings per share of $2.85, excluding notable items, representing a 22% increase from the prior-year quarter. This achievement marks the highest quarterly level in the company's history, driven by broad-based growth across all six business segments. Revenue increased by 12% to $14.1 billion, supported by higher variable investment income, volume growth, and favorable underwriting results.
The company reported net income of $2.4 billion, or $3.67 per share, which was up 187% year-over-year. Adjusted return on equity reached 19.6% excluding notable items, while MetLife confirmed it remains on track to meet its full-year targets for free cash flow and direct expense ratios. Holding-company cash and liquid assets stood at $3.4 billion at quarter-end, aligning with management's target range.
MetLife returned approximately $1 billion to shareholders through share repurchases and common stock dividends during the quarter, highlighting a continued focus on capital returns alongside reinvestment for growth. CEO Michel Khalaf emphasized that the results demonstrate the strength of the New Frontier strategy and the discipline of its execution, citing stronger underwriting and investment returns as key drivers.
The earnings release indicates broad operating momentum rather than growth concentrated in a single division, supporting the case for resilient earnings. MetLife stock traded at 92.45 euros on November 12, 2026, reflecting positive market sentiment following the announcement of these robust financial results and strategic confidence.
Sector and industry come from company profile data. Sentiment is the AI score of the news articles on this page, averaged per day. Not investment advice.
MetLife Inc. reported strong second-quarter 2026 financial results, with earnings per share (EPS) of USD 2.43, beating the consensus estimate by USD 0.13. Revenue for the quarter reached USD 13.52 billion, representing a 10.5% year-over-year increase. The company also posted a net margin of 4.57% and a return on equity of 23.39%, demonstrating solid profitability metrics.
Following the earnings release, MetLife's board authorized a USD 3 billion share repurchase plan while maintaining its quarterly dividend at USD 0.5925 per share. This commitment to capital returns signals confidence in the company's cash flow generation and shareholder value creation strategy amidst a challenging market environment.
Analyst sentiment remains positive, with a consensus Buy rating and an average price target of USD 102.21, which is significantly above the current stock price. Major institutions like Morgan Stanley and Wells Fargo raised their price targets following the report, citing strong operational performance and growth prospects.
At the KBW Insurance Conference, MetLife highlighted that its New Frontier plan is ahead of schedule, projecting 2025 EPS growth of 10% and free cash flow of nearly USD 5 billion. Management also reaffirmed a full-year variable investment income target of USD 1.6 billion and expected cost synergies from the PineBridge acquisition.
MetLife stock traded at USD 78.45 on September 8, 2026, trading below its 52-week high but well above its low. The market capitalization stood at USD 61.41 billion, reflecting investor confidence in the company's strategic initiatives and financial resilience.
📈 MetLife Q2 EPS beat consensus by USD 0.13 to reach USD 2.43.
💰 Revenue grew 10.5% year over year to USD 13.52 billion.
🔄 Company authorized a new USD 3 billion share repurchase plan.
🚀 Morgan Stanley raised price target to USD 111.00 after earnings.
🎯 New Frontier plan projects 10% EPS growth for 2025.
📈 MetLife reported Q2 2026 EPS of USD 2.43, beating the consensus estimate by USD 0.13.
💰 Revenue grew 10.5% year over year to reach USD 13.52 billion in the second quarter.
📉 The company achieved a net margin of 4.57% and a return on equity of 23.39%.
🔄 MetLife authorized a new USD 3 billion share repurchase plan for its shareholders.
💵 The quarterly dividend remains at USD 0.5925 per share, implying an annualized payout of USD 2.37.
📊 Analysts maintain a Buy consensus with an average price target of USD 102.21.
🚀 Morgan Stanley raised its price target from USD 103.00 to USD 111.00 following the earnings.
🏦 Wells Fargo increased its target from USD 101.00 to USD 109.00 in the same update.
🎯 The New Frontier plan is ahead of schedule with projected 2025 EPS growth of 10%.
💸 Management expects nearly USD 5 billion in free cash flow for 2025.
🤝 MetLife anticipates about USD 50 million in annualized cost synergies from the PineBridge deal.
📈 The stock closed at USD 78.45, trading below the 52-week high of USD 100.93.
Bullish Signals
Q2 EPS beat estimates by USD 0.13 at USD 2.43 per share.
Bullish Signals
MetLife beat Q2 EPS estimates by USD 0.13, reporting USD 2.43 per share versus a consensus of USD 2.30.
Revenue surged 10.5% year over year to reach USD 13.52 billion in the second quarter.
The company achieved a robust return on equity of 23.39% and a net margin of 4.57%.
MetLife authorized a substantial USD 3 billion share repurchase plan to return capital to shareholders.
Analysts maintain a Buy consensus with an average price target of USD 102.21, indicating upside potential.
Morgan Stanley raised its price target from USD 103.00 to USD 111.00 following the strong results.
Wells Fargo increased its target from USD 101.00 to USD 109.00, reinforcing positive analyst sentiment.
The New Frontier plan is ahead of schedule with a projected 2025 EPS growth of 10%.
Management forecasts nearly USD 5 billion in free cash flow for the year 2025.
MetLife expects to generate about USD 50 million in annualized cost synergies from the PineBridge acquisition.
MetLife Inc. shares are trading near the upper end of their recent range following a strong performance in Q2 2026, where the company reported earnings per share of USD 2.43, beating analyst consensus estimates by 2.53%. The results were released on August 5, 2026, providing investors with a fresh view of the insurer's profitability and capital generation capabilities.
Beyond the earnings beat, MetLife announced a significant capital return strategy involving a USD 3 billion share buyback authorization approved by its Board of Directors. This program allows the company to repurchase up to 4.8 percent of its outstanding shares through open market purchases, signaling confidence in its financial position and commitment to shareholder value.
Financial metrics for Q2 2026 highlight robust growth, with quarterly revenue reaching USD 13.52 billion, representing a 10.5 percent year-over-year increase. Additionally, the company declared a quarterly dividend of USD 0.5925 per share, offering an annualized yield of approximately 2.4 percent based on recent trading levels.
Analyst sentiment remains positive with a consensus Buy rating and a target price of USD 102.21, suggesting potential medium-term upside from current levels. Institutional ownership stands at nearly 95 percent, while notable investors like NEOS Investment Management increased their stakes, reinforcing confidence in MetLife's earnings trajectory and capital return profile.
📈 MetLife Q2 EPS beat estimates by 2.53% at USD 2.43.
💰 Board authorized new USD 3.0 billion share buyback program.
📊 Quarterly revenue rose 10.5% year-over-year to USD 13.52 billion.
💵 Declared quarterly dividend of USD 0.5925 per share.
🎯 Analysts maintain Buy rating with USD 102.21 target price.
📈 MetLife reported Q2 2026 earnings per share of USD 2.43, beating the consensus estimate of USD 2.37 by 2.53 percent.
💰 The Board of Directors authorized a new share buyback program of USD 3.0 billion on August 5, 2026.
📊 Quarterly revenue for Q2 2026 reached USD 13.52 billion, marking a 10.5 percent year-over-year increase.
💵 MetLife declared a quarterly dividend of USD 0.5925 per share, corresponding to an annualized yield of 2.4 percent.
🎯 Analysts maintain a consensus Buy rating with a target price of USD 102.21, indicating modest upside potential.
🏦 Institutional investors and hedge funds collectively own 94.99 percent of MetLife's outstanding shares.
📈 NEOS Investment Management LLC increased its stake by 13.5 percent in Q2 2026, purchasing an additional 10,646 shares.
🏢 MetLife operates as a global provider of insurance, annuities, and employee benefit programs with a broad product set.
📉 The stock is trading at USD 97.51, near the upper end of its projected 2026 range between USD 90.59 and USD 114.12.
Bullish Signals
MetLife beat Q2 2026 earnings expectations with EPS of USD 2.43 versus a consensus of USD 2.37, demonstrating strong operational performance.
The company generated quarterly revenue of USD 13.52 billion in Q2 2026, achieving a robust 10.5 percent year-over-year growth rate.
MetLife's Board authorized a substantial USD 3.0 billion share buyback program, allowing the repurchase of up to 4.8 percent of outstanding shares.
The insurer declared a quarterly dividend of USD 0.5925 per share, providing an attractive annualized yield of 2.4 percent to income-focused investors.
Analyst consensus maintains a Buy rating with a target price of USD 102.21, suggesting incremental upside from the current trading level of USD 97.51.
Institutional ownership remains high at 94.99 percent, and major investor NEOS Investment Management increased its stake by 13.5 percent in Q2 2026.
MetLife (MET) stock has delivered an 80.7% total return over the past five years, yet valuation models present a mixed picture regarding future upside. While earnings multiples appear reasonable, broader checks suggest the stock is not a clear bargain based on current metrics.
Using an Excess Returns intrinsic value model, MetLife appears undervalued by approximately 44%. The analysis projects a stable book value of $53.18 per share and a cost of equity of $3.99, resulting in an excess return of $4.43 per share that supports a fair value estimate of $169.91.
Conversely, traditional valuation metrics indicate the stock is roughly fairly valued with only a modest premium. MetLife currently trades at a P/E ratio of 17.6x, which is higher than the broader insurance industry average of 11.2x and the peer group average of 14.6x, suggesting the market has already priced in some of its strengths.
📈 MetLife delivered an 80.7% total return over the past five years.
💰 Fair value model implies a 44% discount to current pricing at $169.91.
📊 Company projects stable book value of $53.18 with 15.83% average ROE.
⚖️ MetLife trades at 17.6x P/E, above industry and peer averages.
🔮 Future performance depends on maintaining ROE exceeding cost of capital.
📈 MetLife stock has generated an 80.7% total return for investors over the past five years.
💰 An Excess Returns model estimates a fair value of $169.91 per share, implying a 44% discount to current pricing.
📊 The company projects a stable book value of $53.18 per share with an average return on equity of 15.83%.
⚖️ MetLife trades at a P/E ratio of 17.6x, which is above the industry average of 11.2x and peer average of 14.6x.
📉 Broader valuation checks assign MetLife a low value score of 2 out of 6, indicating it may not be a clear bargain on traditional metrics.
🔮 The stock's future performance depends on maintaining returns on equity that exceed its cost of capital to justify the intrinsic value case.
Bullish Signals
MetLife appears undervalued by 44.0% according to an Excess Returns intrinsic value model based on projected cash generation.
The company is expected to generate a stable book value of $53.18 per share, supporting a high return on equity profile.
Risk Factors
MetLife trades at a P/E ratio of 17.6x, which is significantly above the broader insurance industry average of 11.2x and peer group average of 14.6x.
Broader valuation checks assign the stock a low value score of 2 out of 6, suggesting it may not be a clear bargain on traditional metrics.
MetLife (NYSE:MET) has surged 25.2% year to date, driven by a favorable shift in the interest rate environment where higher Treasury yields act as a direct tailwind for its investment income. The company reported that net investment income rose 10% to $5.36 billion in Q1 2026, while variable investment income surged 58% to $518 million. This performance highlights MetLife's ability to capitalize on elevated reinvestment yields behind its policy float, contrasting sharply with peers facing yield competition.
Management has demonstrated a strong commitment to shareholder returns, returning over $1.10 billion in the first quarter of 2026 alone. The company has also increased its dividend twice this year, raising the quarterly payout from $0.545 to $0.5925 per share. These actions reflect confidence in the sustainability of earnings as long as reinvestment yields remain elevated, positioning MetLife as a primary beneficiary of the current high-rate macroeconomic conditions.
The article positions MetLife as a clear winner among dividend payers reacting to the 30-year Treasury closing at 5.31% on August 17, 2026. While competitors like Realty Income and Verizon face pressure from competing yield alternatives or refinancing costs, MetLife's fixed-versus-floating mix and debt maturity schedule allow it to convert higher rates into immediate earnings growth. The stock's outperformance underscores the importance of specific balance sheet mechanics over broad sector labels in a high-yield environment.
📈 MetLife shares up 25.2% YTD as Treasury yields boost net investment income.
💰 Q1 2026 net investment income rose 10% to $5.36 billion.
📊 Adjusted EPS grew 23% year over year in Q1 2026.
💵 Management returned over $1.10 billion to shareholders in Q1 2026.
🔼 Quarterly dividend raised twice in 2026, increasing from $0.545 to $0.5925.
📈 MetLife shares are up 25.2% year to date as higher Treasury yields directly boost its net investment income.
💰 Q1 2026 net investment income rose 10% to $5.36 billion, with variable investment income surging 58% to $518 million.
📊 Adjusted EPS grew 23% year over year in the first quarter of 2026.
💵 Management returned over $1.10 billion to shareholders in Q1 2026 through dividends and buybacks.
🔼 The quarterly dividend was raised twice in 2026, increasing from $0.545 to $0.5925 per share.
🏦 MetLife benefits from a debt structure where higher reinvestment yields on its float increase earnings.
📉 Competitors like Realty Income face yield competition, whereas MetLife converts rates into profit.
Bullish Signals
Shares gained 25.2% YTD on higher Treasury yields.
Net investment income rose 10% to $5.36B in Q1.
Adjusted EPS grew 23% year over year in Q1.
Returned over $1.10B to shareholders in Q1.
Raised quarterly dividend twice in 2026.
Bullish Signals
MetLife shares have gained 25.2% year to date as the company benefits directly from elevated Treasury yields increasing its investment income.
Net investment income rose 10% to $5.36 billion in Q1 2026, driven by a 58% surge in variable investment income to $518 million.
Adjusted earnings per share grew 23% year over year in the first quarter of 2026.
The company returned over $1.10 billion to shareholders in Q1 2026, demonstrating strong capital allocation.
MetLife raised its quarterly dividend twice in 2026, increasing the payout from $0.545 to $0.5925 per share.
On August 17, 2026, MetLife, Inc. filed a Form 8-K with the U.S. Securities and Exchange Commission to announce dividend declarations for four of its preferred stock series. The filing details specific quarterly or semi-annual dividend rates and liquidation preferences for Series A, D, E, and F, providing precise financial terms for these capital instruments.
The company declared a quarterly dividend of $0.31471411 per share on its Floating Rate Non-Cumulative Preferred Stock, Series A, which carries a $25 liquidation preference. Additionally, a semi-annual dividend of $29.375 per share was announced for the 5.875% Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series D, with a $1,000 liquidation preference.
MetLife also declared dividends for two high-value series: Series E received a quarterly dividend of $351.5625 per share on its 5.625% Non-Cumulative Preferred Stock with a $25,000 liquidation preference, while Series F was assigned a quarterly dividend of $296.875 per share on its 4.75% Non-Cumulative Preferred Stock, also with a $25,000 liquidation preference.
The Form 8-K was signed by Timothy J. Ring, Senior Vice President and Secretary of MetLife, Inc., confirming the declarations under Item 8.01 (Other Events). The filing reiterates that MetLife's common stock is traded on the NYSE under ticker MET with a par value of $0.01 per share.
📅 MetLife filed SEC Form 8-K on August 17, 2026 for preferred stock dividends.
💰 Series A received a quarterly dividend of $0.3147 per share.
📉 Series D declared a semi-annual dividend of $29.375 per share.
💵 Series E granted a quarterly dividend of $351.56 per share.
📊 Series F declared a quarterly dividend of $296.88 per share.
📅 On August 17, 2026, MetLife filed an SEC Form 8-K to declare dividends for four preferred stock series.
💰 Series A received a quarterly dividend of $0.31471411 per share on its Floating Rate Non-Cumulative Preferred Stock.
📉 Series D declared a semi-annual dividend of $29.375 per share on its 5.875% Fixed-to-Floating Rate Non-Cumulative Preferred Stock.
💵 Series E was granted a quarterly dividend of $351.5625 per share on its 5.625% Non-Cumulative Preferred Stock.
📊 Series F declared a quarterly dividend of $296.875 per share on its 4.75% Non-Cumulative Preferred Stock.
🏢 All preferred stock declarations were filed under Item 8.01 (Other Events) of the Form 8-K.
📝 The filing was signed by Timothy J. Ring, Senior Vice President and Secretary of MetLife, Inc.
Bullish Signals
MetLife declared dividends for four preferred stock series on Aug 17, 2026.
Active management confirmed via quarterly and semi-annual dividend declarations.
Bullish Signals
MetLife successfully declared dividends for four distinct preferred stock series (A, D, E, and F) on August 17, 2026, demonstrating the company's ability to meet its capital distribution obligations.
The declaration of specific quarterly and semi-annual dividend rates confirms the active management of MetLife's preferred equity structure and adherence to shareholder agreements.
Bank of Nova Scotia significantly reduced its stake in MetLife, Inc. (NYSE:MET) by 42.1% during the first quarter, selling 155,705 shares to hold a remaining position of 213,846 shares valued at $15.1 million. Conversely, several smaller institutional investors and wealth management firms increased their holdings in the fourth quarter, with Activest Wealth Management boosting its stake by over 200% to own 315 shares.
Wall Street analysts have recently issued mixed but generally positive signals for MetLife. Major institutions including JPMorgan Chase, Wells Fargo, and Jefferies Financial Group raised their price targets to between $101 and $106, maintaining 'overweight' or 'buy' ratings. The consensus average price target stands at $100.50 with a 'Moderate Buy' rating, though Wall Street Zen recently downgraded the stock to a 'hold'.
MetLife reported quarterly earnings on May 6th that beat EPS expectations of $2.27 with a result of $2.42, although revenue of $14.18 billion missed analyst estimates of $19.49 billion. The company maintains a market capitalization of $60.91 billion and has announced a quarterly dividend of $0.5925 per share payable on September 8th to shareholders of record on August 4th.
📉 Bank of Nova Scotia sold 155,705 shares, retaining $15.1M stake.
📈 Activest Wealth Management increased holdings by 205.8% to $25,000.
💰 Analysts raised price targets to average $100.50 with 'Moderate Buy' rating.
📊 MetLife Q1 EPS beat estimates while revenue missed consensus.
💵 Company declared quarterly dividend of $0.5925 per share.
📉 Bank of Nova Scotia decreased its MetLife position by 42.1% in Q1, selling 155,705 shares while retaining a stake worth $15.1 million.
📈 Activest Wealth Management increased its MetLife holdings by 205.8% in Q4 to own 315 shares valued at $25,000.
💰 JPMorgan Chase raised its price target on MetLife from $96.00 to $106.00 with an 'overweight' rating.
📊 Wells Fargo increased its target price from $95.00 to $101.00 and maintained an 'overweight' stance.
🎯 Piper Sandler boosted its price target to $90.00 while keeping a 'neutral' rating on the stock.
📉 MetLife reported Q1 EPS of $2.42, beating estimates, but revenue of $14.18 billion missed the $19.49 billion consensus.
💵 The company declared a quarterly dividend of $0.5925 per share with an annualized yield of 2.5%.
📈 MetLife's stock trades at a P/E ratio of 18.35 with a market cap of $60.91 billion.
🏦 Hedge funds and institutional investors collectively own 94.99% of the company's outstanding shares.
🗣️ Analyst consensus currently rates MetLife as a 'Moderate Buy' with an average price target of $100.50.
Bullish Signals
JPMorgan raised target to $106 with 'overweight' rating.
Wells Fargo increased target to $101, signaling positive outlook.
Jefferies raised target to $103 and upgraded to 'buy'.
MetLife beat EPS estimates, reporting $2.42 per share.
Company maintains 22.60% ROE and 4.66% net margin.
Activest Wealth increased stake by over 200%.
MetLife offers 2.5% dividend yield with 45.93% payout ratio.
Risk Factors
Bank of Nova Scotia cut position by 42.1% in Q1.
MetLife revenue of $14.18B missed $19.49B estimates significantly.
Wall Street Zen downgraded stock from buy to hold.
Stock nears 52-week high of $94.86, limiting upside.
Bullish Signals
JPMorgan Chase raised its price target to $106.00 and assigned an 'overweight' rating, indicating strong institutional confidence.
Wells Fargo increased its price target to $101.00 with an 'overweight' rating, signaling positive outlook from major banks.
Jefferies Financial Group raised its target price to $103.00 and upgraded the rating to 'buy'.
MetLife beat quarterly EPS estimates of $2.27 by reporting $2.42 per share.
The company maintains a healthy return on equity of 22.60% and a net margin of 4.66%.
Activest Wealth Management significantly increased its stake by over 200%, suggesting bullish sentiment among smaller funds.
MetLife offers a consistent dividend yield of 2.5% with a payout ratio of 45.93%.
Risk Factors
Bank of Nova Scotia reduced its position by 42.1% in Q1, indicating a lack of interest from one of the largest institutional holders.
MetLife's quarterly revenue of $14.18 billion missed analyst estimates of $19.49 billion significantly.
Wall Street Zen downgraded MetLife from 'buy' to 'hold', reflecting some caution among analysts.
The stock is trading near its 52-week high of $94.86, which may limit immediate upside potential.
Andra AP fonden established a new position in MetLife, Inc. (NYSE:MET) by purchasing 31,400 shares valued at approximately $2.22 million during the first quarter, according to recent SEC filings. Several other institutional investors also increased their stakes in the fourth quarter, including Activest Wealth Management which lifted its holdings by over 200%, and Sound Income Strategies LLC which boosted its stake by nearly 60%. These new positions indicate growing institutional interest in the financial services provider.
Analyst sentiment remains predominantly positive with major firms raising price targets and maintaining buy ratings. Jefferies Financial Group increased its target price to $103, while TD Cowen raised its objective to $105. Weiss Ratings upgraded MetLife from a 'buy (b-)' to a 'buy (b)', and UBS Group lifted its price objective to $105. The consensus average rating is currently a 'Moderate Buy' with an average target price of $100.50, suggesting analysts see potential upside from current levels.
MetLife recently reported earnings for the quarter ended May 6th, posting EPS of $2.42 which beat analyst estimates of $2.27. However, revenue came in at $14.18 billion, significantly below the consensus estimate of $19.49 billion, though it represented a 2.7% year-over-year increase. The company maintains a market capitalization of $59.61 billion and has declared a quarterly dividend of $0.5925 per share payable on September 8th to shareholders of record on August 4th.
📈 Andra AP fonden bought 31,400 MetLife shares worth $2.22 million in Q1.
📊 Activest Wealth Management holdings surged 205.8% while Sound Income Strategies rose 58.9%.
💰 MetLife beat EPS estimates at $2.42 but missed revenue targets of $19.49 billion.
💵 Quarterly dividend is $0.5925 per share with a 2.6% annualized yield.
🏦 Global insurance provider headquartered in New York City with $59.61 billion market cap.
📈 Andra AP fonden purchased a new position in MetLife consisting of 31,400 shares valued at approximately $2.22 million during the first quarter.
📊 Activest Wealth Management increased its holdings by 205.8% in the fourth quarter, while Sound Income Strategies LLC boosted its stake by 58.9%.
📈 Jefferies Financial Group raised its price target to $103 and TD Cowen increased its objective to $105, both maintaining buy ratings.
💰 MetLife reported quarterly EPS of $2.42, beating analyst estimates of $2.27, though revenue of $14.18 billion missed the consensus forecast of $19.49 billion.
📉 The stock has a 52-week high of $94.86 and a low of $67.33, currently trading with a market cap of $59.61 billion.
💵 MetLife declared a quarterly dividend of $0.5925 per share, representing an annualized yield of 2.6% payable on September 8th.
🏦 The company operates as a global provider of insurance, annuities, and employee benefit programs with headquarters in New York City.
📉 Revenue for the quarter was up 2.7% compared to the same period last year despite missing absolute analyst expectations.
Bullish Signals
Activest Wealth Management increased stake by over 200%.
Weiss Ratings upgraded MetLife to a 'buy (b)' rating.
MetLife beat EPS estimates with reported $2.42 vs $2.27.
Solid dividend yield of 2.6% with 45.93% payout ratio.
Revenue grew 2.7% year-over-year to $14.18 billion.
Risk Factors
Revenue of $14.18B missed consensus estimate of $19.49B.
Bank of America lowered price target from $103.00 to $99.00.
Bullish Signals
Andra AP fonden initiated a significant new position of $2.22 million, signaling strong institutional confidence in the company.
Activest Wealth Management increased its stake by over 200% and Sound Income Strategies LLC boosted holdings by nearly 60% in the fourth quarter.
Jefferies Financial Group raised its price target to $103 and TD Cowen lifted its objective to $105, both reaffirming buy ratings.
Weiss Ratings upgraded MetLife from a 'buy (b-)' to a 'buy (b)', indicating improved credit or fundamental outlook.
MetLife beat quarterly earnings per share estimates with reported EPS of $2.42 versus the consensus of $2.27.
The company maintains a solid dividend yield of 2.6% with a payout ratio of 45.93%, providing income to shareholders.
Revenue grew by 2.7% year-over-year to $14.18 billion, demonstrating organic business growth despite missing absolute targets.
The average analyst price target of $100.50 suggests potential upside from recent trading levels.
Risk Factors
MetLife's quarterly revenue of $14.18 billion significantly missed the analyst consensus estimate of $19.49 billion.
Bank of America lowered its price target on MetLife shares from $103.00 to $99.00, though it maintained a buy rating.
Dimensional Fund Advisors LP reduced its position in MetLife, Inc. (NYSE:MET) by 5.1% during the first quarter, selling 383,075 shares to hold approximately 7.12 million shares valued at $503.64 million, representing about 1.09% of the company's outstanding stock.
Several other institutional investors adjusted their stakes in MetLife during the fourth quarter, with Strs Ohio increasing holdings by 16.6%, Evergreen Capital Management rising its stake by 195.8%, and PFA Pension Forsikringsaktieselskab establishing a new position valued at $81.49 million.
MetLife shares opened at $93.00, trading above its 50-day moving average of $86.11 and 200-day moving average of $79.16, with a market capitalization of $59.84 billion and a P/E ratio of 18.02.
The company announced a quarterly dividend of $0.5925 per share payable on September 8th to stockholders of record as of August 4th, resulting in an annualized dividend yield of 2.5% and a payout ratio of 45.93%.
📉 DFA sold 383,075 shares, reducing stake by 5.1%.
🚀 Evergreen Capital boosted holdings by 195.8% with 22,016 shares.
💰 PFA Pension entered new position valued at $81.49 million.
💵 Quarterly dividend of $0.5925 payable on September 8th.
📉 Dimensional Fund Advisors LP reduced its MetLife stake by 5.1%, selling 383,075 shares in the first quarter.
📈 Strs Ohio increased its MetLife holdings by 16.6% to own 326,091 shares worth $25.74 million.
🚀 Evergreen Capital Management LLC boosted its stake by 195.8%, acquiring an additional 22,016 shares.
💰 PFA Pension Forsikringsaktieselskab acquired a new position in MetLife valued at $81.49 million.
📊 Diversified Trust Co. increased its stake by 276.4% to own 31,246 shares worth $2.47 million.
🏢 Universal Beteiligungs und Servicegesellschaft mbH raised its stake by 2.1% to hold 714,193 shares.
📉 MetLife stock opened at $93.00 with a market cap of $59.84 billion and a P/E ratio of 18.02.
💵 The company declared a quarterly dividend of $0.5925 per share payable on September 8th.
📈 Analyst consensus target price is $98.57 with an average rating of 'Moderate Buy' from Wall Street Zen and others.
🏛️ MetLife maintains a debt-to-equity ratio of 0.53 and a quick ratio of 0.20.
Bullish Signals
Trading above 50-day ($86.11) and 200-day ($79.16) moving averages.
Analyst target price $98.57 with upgrades to $105.00 and $94.00.
Institutional ownership stands high at 94.99%.
Dividend yield of 2.5% with sustainable 45.93% payout ratio.
Risk Factors
Major holder DFA cut position by 5.1%, selling 383k shares.
Current and quick ratios at 0.20 signal severe liquidity risks.
Bullish Signals
MetLife shares are trading above both the 50-day moving average ($86.11) and the 200-day moving average ($79.16), indicating positive short-to-medium-term momentum.
The company has a strong analyst consensus with an average target price of $98.57, supported by upgrades from Keefe, Bruyette & Woods to $105.00 and Barclays to $94.00.
Institutional ownership remains high at 94.99%, demonstrating continued confidence from major investors despite some position reductions.
MetLife offers a solid dividend yield of 2.5% with a sustainable payout ratio of 45.93%, providing income to shareholders.
Risk Factors
Dimensional Fund Advisors LP, a significant institutional holder, reduced its position by 5.1% in the first quarter, selling over 383,000 shares.
The company's current ratio and quick ratio are both at 0.20, indicating potential liquidity constraints relative to short-term obligations.
Boston Common Asset Management LLC reduced its stake in MetLife, Inc. (NYSE:MET) by 11.2% during the first quarter, selling 13,810 shares to hold a remaining position of 109,516 shares valued at $7.745 million according to recent SEC filings.
Conversely, several smaller institutional investors increased their positions in MetLife during the fourth quarter. Activest Wealth Management raised its stake by 205.8% to own 315 shares worth $25,000, while Sound Income Strategies LLC grew its holding by 58.9% to 383 shares valued at $29,000.
MetLife recently reported quarterly earnings on May 6th, posting $2.42 per share which beat the consensus estimate of $2.27. However, revenue came in at $14.18 billion, significantly below the expected $19.49 billion, resulting in a net margin of 4.66% and year-over-year revenue growth of only 2.7%.
The company maintains a market capitalization of $60.48 billion with a dividend yield of 2.5%, set to be paid on September 8th to shareholders of record on August 4th. MetLife trades at a PE ratio of 18.21 and has seen its stock price fluctuate between a one-year low of $67.33 and a high of $94.86.
📉 Boston Common Asset Management reduced MetLife stake by 11.2% to 109,516 shares.
📈 Activest Wealth Management increased position by 205.8% to 315 shares.
📊 Q1 EPS beat estimates at $2.42 despite revenue miss of $14.18 billion.
💰 Quarterly dividend declared at $0.5925 per share with 2.5% yield.
🏢 Global insurance provider headquartered in New York City with $60.48B market cap.
📉 Boston Common Asset Management LLC trimmed its MetLife stake by 11.2% in Q1, reducing holdings to 109,516 shares valued at $7.745 million.
📈 Activest Wealth Management significantly increased its position by 205.8% in Q4, now owning 315 shares worth $25,000.
📊 MetLife reported Q1 EPS of $2.42, beating analyst estimates of $2.27 despite revenue missing expectations at $14.18 billion versus a consensus of $19.49 billion.
💰 The company declared a quarterly dividend of $0.5925 per share, offering a 2.5% yield to shareholders of record on August 4th.
📈 MetLife shares currently trade at a PE ratio of 18.21 with a market capitalization of $60.48 billion.
🏢 The firm operates as a global provider of insurance, annuities, and employee benefit programs headquartered in New York City.
Bullish Signals
MetLife beat EPS estimates by $0.15 at $2.42.
Strong ROE of 22.60% with manageable debt-to-equity of 0.53.
Institutional investors Activest Wealth and Sound Income increased stakes.
Risk Factors
Q1 revenue missed estimates by $5.31 billion.
Year-over-year revenue growth was only 2.7%.
Bullish Signals
MetLife beat quarterly earnings per share estimates by $0.15, reporting $2.42 EPS against a consensus of $2.27.
The company maintains a strong return on equity of 22.60% and a manageable debt-to-equity ratio of 0.53.
Activest Wealth Management and Sound Income Strategies LLC increased their stakes, indicating continued institutional interest in the stock.
Risk Factors
MetLife's Q1 revenue of $14.18 billion fell significantly short of the consensus estimate of $19.49 billion.
The company's year-over-year revenue growth was modest at only 2.7% compared to the same quarter last year.
AIA Group Ltd significantly increased its stake in MetLife, Inc. (NYSE: MET) by 150% during the first quarter, purchasing an additional 114,997 shares to hold a total of 191,638 shares valued at $13.55 million. Several other institutional investors also adjusted their positions, with Empowered Funds LLC increasing its stake by 187.6% and new stakes taken by Sivia Capital Partners LLC and Jump Financial LLC in the second quarter.
MetLife reported quarterly earnings on May 6th, posting $2.42 per share which beat analyst consensus estimates of $2.27. However, revenue came in at $14.18 billion, falling short of the estimated $19.49 billion, resulting in a year-over-year revenue increase of only 2.7%. The company achieved a net margin of 4.66% and a return on equity of 22.60%, with analysts forecasting full-year earnings of $9.94 per share.
The stock recently opened at $93.99, trading near its 12-month high of $94.86 with a market capitalization of $60.48 billion and a P/E ratio of 18.21. MetLife maintains a dividend yield of 2.5% with an upcoming payment of $0.5925 per share to stockholders of record on August 4th, reflecting a payout ratio of 45.93%. The company operates as a global provider of insurance, annuities, and employee benefit programs headquartered in New York City.
📈 AIA Group boosted MetLife holdings by 150% in Q1.
📉 Revenue missed estimates at $14.18 billion despite beating EPS.
💰 EPS of $2.42 surpassed consensus estimate of $2.27.
💵 Stock trades at P/E of 18.21 with $60.48B market cap.
📅 Quarterly dividend of $0.5925 payable Sept 8th to record holders.
📈 AIA Group Ltd boosted its MetLife holdings by 150% in Q1, adding 114,997 shares to a total position of 191,638 shares.
📉 MetLife reported revenue of $14.18 billion for the quarter, which missed analyst estimates of $19.49 billion despite beating EPS expectations.
💰 The company posted earnings per share of $2.42, surpassing the consensus estimate of $2.27 by $0.15.
📊 MetLife achieved a net margin of 4.66% and a return on equity of 22.60% during the reported quarter.
💵 The stock trades at a P/E ratio of 18.21 with a market capitalization of $60.48 billion.
📅 MetLife announced a quarterly dividend of $0.5925 per share payable on September 8th to record holders as of August 4th.
🏦 The company maintains a debt-to-equity ratio of 0.53 and a current ratio of 0.20.
📈 Analysts forecast full-year earnings of $9.94 per share for MetLife, Inc.
Bullish Signals
Institutional stake surged 150% in Q1.
Beat EPS estimates at $2.42 vs $2.27.
Healthy ROE of 22.60% and net margin of 4.66%.
Attractive 2.5% dividend yield with 45.93% payout.
Risk Factors
Revenue missed estimates: $14.18B vs $19.49B expected.
Modest YoY growth of only 2.7%.
Bullish Signals
AIA Group Ltd increased its stake in MetLife by 150% in the first quarter, signaling strong institutional confidence in the financial services provider.
MetLife beat quarterly earnings estimates with $2.42 EPS compared to the consensus of $2.27.
The company maintains a healthy return on equity of 22.60% and a net margin of 4.66%.
MetLife offers an attractive dividend yield of 2.5% with a sustainable payout ratio of 45.93%.
Risk Factors
MetLife's quarterly revenue of $14.18 billion significantly missed analyst estimates of $19.49 billion, indicating potential headwinds in core business segments.
The company's year-over-year revenue growth was modest at only 2.7%, suggesting limited expansion momentum.
Bank of New York Mellon Corp reduced its stake in MetLife, Inc. (NYSE:MET) by 25.8% during the first quarter, selling over 1.24 million shares to hold a remaining position valued at approximately $253 million. Conversely, several other major institutional investors increased their holdings significantly in the fourth and third quarters, including Vanguard Group, which added roughly 7.8 million shares worth nearly $5.7 billion, and Pzena Investment Management, which boosted its position by 22.9%.
MetLife's stock recently opened at $93.99 with a market capitalization of $60.48 billion. The company maintains a dividend yield of 2.5%, set to pay $0.5925 per share on September 8th for shareholders of record on August 4th. Analyst sentiment remains generally positive, with an average target price of $98.57 and a consensus rating of 'Moderate Buy' from Wall Street firms like UBS and Jefferies.
MetLife operates as a global provider of insurance, annuities, and employee benefit programs headquartered in New York City. Its core business segments include life insurance, group benefits, retirement products such as annuities, and supplemental health coverage including dental and disability plans distributed through employer-sponsored programs.
📉 BNY Mellon sold 1.24M shares, retaining $253M stake.
📈 Vanguard added 7.8M shares worth $5.7B in Q4.
📈 Pzena raised position by 22.9% to own $938M.
💰 MetLife pays $0.5925 dividend with 2.5% yield.
📊 Stock trades at 18.21 P/E ratio and $60.48B cap.
📉 Bank of New York Mellon Corp reduced its MetLife holdings by 25.8% in Q1, selling 1,241,561 shares while retaining a $253 million position.
📈 Vanguard Group increased its stake by 12.1% in Q4, adding 7,805,814 shares valued at approximately $5.7 billion.
📈 Pzena Investment Management LLC raised its position by 22.9% in Q4 to own 11,883,338 shares worth roughly $938 million.
📈 AQR Capital Management and Man Group plc also significantly increased their MetLife positions during the third and second quarters respectively.
💰 MetLife announced a quarterly dividend of $0.5925 per share with an ex-dividend date of August 4th, offering a 2.5% yield.
📊 The stock trades at a P/E ratio of 18.21 and has a market cap of $60.48 billion as of the latest trading session.
🏦 UBS Group raised its price target to $105.00 with a 'buy' rating, while Jefferies Financial Group set a $103.00 objective.
📉 Wall Street Zen downgraded MetLife from 'buy' to 'hold', though the average analyst consensus remains a 'Moderate Buy'.
Bullish Signals
Major investors like Vanguard increased stakes in MetLife.
Solid 2.5% dividend yield with 45.93% payout ratio.
UBS and Jefferies issued buy ratings with raised targets.
Strong global market position in life insurance and annuities.
Risk Factors
BNY Mellon cut holdings by over 25% in Q1.
Wall Street Zen downgraded stock from buy to hold.
Bullish Signals
Major institutional investors like Vanguard, Pzena, and AQR have increased their stakes in MetLife during recent quarters, indicating continued confidence in the company's long-term prospects.
MetLife maintains a solid dividend yield of 2.5% with a payout ratio of 45.93%, providing consistent income to shareholders.
Multiple brokerages including UBS and Jefferies have issued 'buy' ratings and raised price targets above the current trading price.
The company holds a strong market position as a global provider of life insurance, annuities, and employee benefit programs.
Risk Factors
Bank of New York Mellon Corp significantly reduced its holdings by over 25% in Q1, signaling a lack of confidence from at least one major institutional investor.
Wall Street Zen downgraded the stock from 'buy' to 'hold', reflecting some divergence in analyst sentiment regarding the company's valuation or outlook.
Swedbank AB, a registered investment adviser, initiated a new position in MetLife, Inc. (NYSE:MET) during the second quarter of 2026, as disclosed in its latest 13F filing with the Securities and Exchange Commission.
The institutional investor purchased approximately 2,473,037 shares of the financial services company, valued at roughly $209.2 million based on the stock price at the time of the filing. MetLife's stock was trading at $91.94 per share with a total market capitalization of $54.2 billion.
This new stake represents a significant institutional holding that signals growing confidence in MetLife's prospects, suggesting the asset manager views the stock as undervalued or poised for growth following months of due diligence.
Analysts and retail investors often monitor such 13F filings to identify smart money flows, noting that these positions reflect broader views on credit conditions, interest rate expectations, and the profitability outlook for the banking and financial services sector.
📈 Swedbank initiated a new MetLife position in Q2 2026.
💰 Purchase included 2,473,037 shares valued at $209.2 million.
🏦 MetLife trades at $91.94 with a $54.2 billion market cap.
📊 New stake makes Swedbank a significant institutional holder.
🔍 13F filings reflect holdings as of quarter end dates.
📈 Swedbank AB initiated a new position in MetLife, Inc. (MET) during Q2 2026.
💰 The purchase consisted of 2,473,037 shares valued at approximately $209.2 million.
🏦 MetLife's stock trades at $91.94 with a market capitalization of $54.2 billion.
📊 The new stake places Swedbank among the more significant institutional holders in MET.
🔍 13F filings reflect holdings as of the quarter end and are filed up to 45 days later.
📉 Institutional moves in MetLife may reflect broader views on credit conditions and interest rates.
🤝 Large positions like this one can influence trading dynamics and attract market attention.
📑 13F filings are quarterly SEC reports required for institutional managers with over $100 million in assets.
Bullish Signals
Swedbank AB initiated a new position in MetLife.
Substantial $209.2 million purchase suggests undervaluation.
Swedbank AB initiated a new position in MetLife, indicating growing institutional confidence in the company's prospects.
The substantial purchase of $209.2 million suggests that large asset managers view MetLife as undervalued or poised for growth.
A significant new institutional holding can influence trading dynamics and signal to other market participants that the stock is attracting smart money.
MetLife Inc. (NYSE:MET) recently reported a strong first quarter of 2024, with adjusted earnings rising 20% year-over-year to $1.3 billion, or $1.83 per share. The company also increased its share repurchase authorization to $3 billion and saw adjusted premium fees and other revenues grow by 4% to $12 billion compared to the same quarter last year.
Despite these positive earnings results, analyst Piper Sandler lowered its price target on MetLife shares from $85 to $82 while maintaining an Overweight rating. The downgrade was driven by increased Group Benefits claims, specifically in dental coverage, a trend observed across the industry during this earnings season. However, Piper Sandler noted that excluding these specific claims, MetLife's earnings remained consistent with prior projections.
MetLife serves over 90 million customers across more than 60 countries as one of the world's largest providers of insurance and annuities. Hedge fund sentiment remains positive, with 36 funds holding significant stakes in the company as of Q1 2024, led by Pzena Investment Management. The article ranks MetLife 10th on a list of best health insurance stocks to buy, though the author suggests AI stocks may offer higher returns.
📈 MetLife Q1 adjusted earnings rose 20% to $1.3 billion.
💰 Share repurchase authorization increased to $3 billion.
📊 Adjusted premium fees and other revenues grew 4%.
⚠️ Piper Sandler lowered price target to $82 due to dental claims.
🏆 36 hedge funds hold significant stakes in MetLife.
📈 MetLife reported a 20% year-over-year rise in adjusted earnings to $1.3 billion ($1.83 per share) for Q1 2024.
💰 The company increased its share repurchase authorization to $3 billion following a strong first quarter performance.
📊 Adjusted premium fees and other revenues grew by 4% year-over-year, totaling $12 billion in the first quarter.
⚠️ Piper Sandler lowered its price target on MetLife shares from $85 to $82 due to increased Group Benefits claims in dental.
🏆 Hedge fund sentiment is positive with 36 funds holding significant stakes, led by Pzena Investment Management.
🌍 MetLife serves over 90 million customers across more than 60 countries as a major global insurer.
📉 Analyst Piper Sandler maintains an Overweight rating despite the price target reduction following earnings.
Bullish Signals
Adjusted earnings rose 20% YoY to $1.3B.
Share repurchase authorization increased to $3B.
Premium fees grew 4% YoY to $12B.
36 hedge funds hold significant stakes.
Risk Factors
Piper Sandler cut price target to $82 due to higher dental claims.
Bullish Signals
MetLife achieved a substantial 20% year-over-year increase in adjusted earnings, reaching $1.3 billion for Q1 2024.
The company successfully increased its share repurchase authorization to $3 billion, signaling confidence in its capital position.
Adjusted premium fees and other revenues grew by 4% year-over-year to reach $12 billion in the first quarter.
Hedge fund sentiment remains robust with 36 funds holding significant stakes in MetLife as of Q1 2024.
Risk Factors
Piper Sandler lowered its price target on MetLife shares from $85 to $82 following an increase in Group Benefits claims, particularly in dental.
Zurich Insurance and Farmers Exchanges have officially closed their acquisition of MetLife's U.S. property and casualty business for a total price of $3.94 billion. The transaction involves the purchase of 2.4 million existing Auto & Home policies, which generated $3.6 billion in net written premiums during 2019, along with approximately 3,500 employees.
This strategic move significantly expands Farmers' national footprint, transforming it into a major personal lines carrier across the United States. Jeff Dailey, CEO of Farmers Group, described the deal as a milestone that will make Farmers-branded products available nationwide, offering consumers broader choices for auto and home coverage from coast to coast.
The financial structure of the deal saw Zurich's Farmers Group Inc unit contribute $2.43 billion while the Farmers Exchanges contributed $1.51 billion. Additionally, the Farmers Exchanges secured a 10-year exclusive distribution agreement with MetLife to offer personal lines products on MetLife's Group Benefits platform, reaching roughly 37 million eligible employees across 3,800 employers.
MetLife President and CEO Michel Khalaf stated that divesting this business allows the life insurer to concentrate on its core strengths. The acquired policies will retain their current terms but will be rebranded under the Farmers name, solidifying Zurich's long-term presence in the U.S. market following its 1998 acquisition of Farmers Group.
🤝 Zurich and Farmers buy MetLife U.S. P&C business for $3.94 billion.
📊 Deal covers 2.4 million policies and $3.6 billion in 2019 premiums.
👥 Integration brings 3,500 employees into the combined Farmers organization.
🇺🇸 Acquisition establishes Farmers as a major nationwide U.S. personal lines insurer.
📜 Includes 10-year exclusive distribution deal for 37 million eligible employees.
🤝 Zurich Insurance and Farmers Exchanges have finalized the purchase of MetLife's U.S. property/casualty business for $3.94 billion.
📊 The acquired portfolio includes 2.4 million policies and $3.6 billion in net written premiums recorded in 2019.
👥 Approximately 3,500 employees are being integrated into the combined Farmers organization following the deal closure.
🇺🇸 The acquisition grants Farmers a nationwide presence, establishing it as a major player in U.S. personal lines insurance.
💰 Zurich's Farmers Group Inc unit contributed $2.43 billion while the Farmers Exchanges contributed $1.51 billion to the total cost.
📜 A 10-year exclusive distribution agreement was signed to offer Farmers products on MetLife's Group Benefits platform.
👥 The new arrangement covers approximately 3,800 employers and reaches about 37 million eligible employees via the Group Benefits channel.
🔄 Acquired policies will remain unchanged except for a rebranding switch to the Farmers name.
🎯 MetLife CEO Michel Khalaf confirmed the sale allows the company to refocus on its core life insurance strengths.
🏛️ Jeff Dailey, CEO of Farmers Group, labeled the transaction a historic milestone in the company's nearly 100-year history.
Bullish Signals
Acquired MetLife business for dominant U.S. personal lines carrier position.
Accessed 2.4 million policies and $3.6 billion in annual premiums.
Secured 10-year exclusive deal with 37 million eligible employees.
Farmers has successfully expanded its national footprint by acquiring MetLife's business, securing a dominant position as a major personal lines carrier in the U.S.
The deal provides immediate access to 2.4 million policies and $3.6 billion in annual premiums, significantly boosting revenue potential.
Farmers secured a strategic 10-year exclusive distribution agreement with MetLife, gaining access to a massive network of 37 million eligible employees.
CEO Jeff Dailey highlighted the deal as a transformative milestone that enhances consumer choice and engagement opportunities nationwide.
Fjarde AP Fonden, a major Swedish national pension fund, significantly increased its stake in MetLife (NYSE:MET) by 99.6% during the first quarter, purchasing an additional 95,650 shares to hold a total of 191,665 shares valued at $13.555 million. This move was part of broader institutional activity where several other investors, including Elevation Point Wealth Partners and Keybank National Association, also raised their positions in the financial services provider.
MetLife's stock performance metrics show a market capitalization of $57.84 billion with a P/E ratio of 17.42. The company recently paid a quarterly dividend of $0.5925 per share on June 9th, representing an annualized yield of 2.6% and a payout ratio of 45.93%. Analyst sentiment remains mixed but generally positive, with an average target price of $95.62 from Wall Street Zen's 'Moderate Buy' rating.
Analyst ratings vary across major firms, with Keefe, Bruyette & Woods raising their price target to $98.00 and giving an 'outperform' rating, while Bank of America and TD Cowen maintained 'buy' ratings despite lowering their price targets. The stock currently trades near its 52-week high of $90.06, trading above both its 50-day and 200-day moving averages, indicating sustained investor interest in the insurer's core life insurance and retirement product businesses.
📈 Fjarde AP Fonden increased MetLife holdings by 99.6% to $13.555 million.
💰 MetLife paid a quarterly dividend of $0.5925 with a 2.6% yield.
📉 Wall Street Zen lowered rating to 'hold' while KBW raised target to $98.
🏦 Bank of America and TD Cowen maintained 'buy' ratings on the stock.
📊 Institutional investors own 94.99% of MetLife's outstanding shares.
📈 Fjarde AP Fonden increased its MetLife holdings by 99.6% to 191,665 shares worth $13.555 million in Q1.
📊 Other institutional investors like Elevation Point Wealth Partners and Keybank also raised their stakes in the company.
💰 MetLife paid a quarterly dividend of $0.5925 per share on June 9th with an annualized yield of 2.6%.
📉 Wall Street Zen lowered its rating to 'hold', while Keefe, Bruyette & Woods raised the price target to $98.00.
🏦 Bank of America and TD Cowen maintained 'buy' ratings despite reducing their price targets slightly.
📈 The stock trades at a P/E ratio of 17.42 with a market cap of $57.84 billion.
📉 MetLife's debt-to-equity ratio stands at 0.53, indicating a moderate leverage position.
📊 Institutional investors and hedge funds collectively own 94.99% of the company's outstanding stock.
Bullish Signals
Fjarde AP Fonden nearly doubled stake with 95,650 shares.
Analysts raised price target to $98.00 with outperform rating.
Stock trades above 50-day and 200-day moving averages.
Risk Factors
Wall Street Zen downgraded MetLife from buy to hold.
Quick and current ratios at 0.20 signal tight liquidity.
Bullish Signals
Major institutional investor Fjarde AP Fonden nearly doubled its stake in MetLife by adding 95,650 shares, signaling strong confidence in the company's long-term prospects.
Several other institutional investors including Elevation Point Wealth Partners and Keybank increased their holdings, suggesting broad-based institutional support.
MetLife raised its quarterly dividend to $0.5925 per share from the previous $0.57, demonstrating a commitment to returning value to shareholders.
Keefe, Bruyette & Woods raised its price target to $98.00 and assigned an 'outperform' rating, reflecting positive analyst sentiment on the stock's valuation.
The stock is trading above both its 50-day and 200-day moving averages, indicating sustained upward momentum and investor interest.
Risk Factors
Wall Street Zen downgraded MetLife from a 'buy' to a 'hold' rating, introducing some caution regarding the stock's immediate outlook.
MetLife's quick ratio and current ratio are both at 0.20, indicating a relatively tight liquidity position that could be a concern during periods of market stress.
MetLife (NYSE:MET) reported first-quarter earnings of $2.42 per share, surpassing analyst expectations of $2.27, while revenue increased 2.7% year-over-year to $14.18 billion. The company also raised its quarterly dividend to $0.5925 per share, resulting in an annualized yield of approximately 2.8%. Financial metrics show a net margin of 4.66%, a return on equity of 22.60%, and a market capitalization of $55.38 billion.
Institutional investors have significantly increased their stakes in MetLife during the recent quarter. Janney Montgomery Scott LLC boosted its position by 8.8% to hold 532,758 shares valued at roughly $37.7 million. Other major holders including Vanguard Group, Dodge & Cox, Wellington Management, Pzena Investment Management, and Norges Bank also added to their holdings, with institutional ownership standing at 94.9%.
Wall Street analysts maintain a Moderate Buy consensus with a target price around $95.62. Recent rating upgrades include Wells Fargo raising its target to $95.00, JPMorgan Chase increasing it to $96.00, and Keefe, Bruyette & Woods setting a target of $98.00. The stock currently trades near its 52-week high of $89.62 with a price-to-earnings ratio of 16.68.
📈 Q1 EPS beat estimates at $2.42.
💰 Revenue grew 2.7% to $14.18 billion.
🏦 Janney Montgomery Scott increased stake by 8.8%.
🔝 Vanguard Group position grew 12.1%.
🎯 Analyst target price is approximately $95.62.
📈 MetLife reported Q1 EPS of $2.42, beating analyst estimates of $2.27.
💰 Revenue grew 2.7% year-over-year to reach $14.18 billion in the first quarter.
📉 The company raised its quarterly dividend to $0.5925, offering a 2.8% annualized yield.
🏦 Janney Montgomery Scott LLC increased its stake by 8.8% to own 532,758 shares.
🔝 Vanguard Group grew its position by 12.1% in the fourth quarter.
📊 Institutional ownership of MetLife stock stands at 94.9%.
🎯 Analyst consensus target price is approximately $95.62 with a Moderate Buy rating.
🚀 Wells Fargo raised its price target to $95.00 and issued an overweight rating.
📈 Keefe, Bruyette & Woods increased its target price to $98.00 with an outperform rating.
💵 MetLife trades at a PEG ratio of 0.64 and a market cap of $55.38 billion.
ABN AMRO Bank N.V. significantly reduced its stake in MetLife, Inc. (NYSE:MET) by 96.1% during the first quarter, selling over 2.1 million shares and holding a remaining position valued at approximately $6.08 million. Conversely, several other institutional investors increased their holdings, including Nordea Investment Management AB, which grew its stake by 2.6%, and Korea Investment CORP, which added to its position by 12.1% in the third quarter.
Analyst sentiment remains generally positive with major firms like Wells Fargo, Morgan Stanley, JPMorgan Chase, and Weiss Ratings raising their price targets or upgrading ratings to 'overweight' or 'buy'. The consensus target price stands at $95.62, reflecting a moderate buy rating from MarketBeat.com, though TD Cowen recently lowered its target to $88.00.
MetLife reported strong quarterly earnings with EPS of $2.42, beating the consensus estimate of $2.27, and achieved a return on equity of 22.60%. However, revenue of $14.18 billion fell short of analyst expectations of $19.49 billion, though it grew 2.7% year-over-year. The company also increased its quarterly dividend to $0.5925 per share, offering a yield of 2.8%.
📉 ABN AMRO cut MetLife stake by 96.1% selling over 2 million shares.
📈 Nordea and Korea Investment increased holdings totaling nearly $420 million.
MetLife Inc. (MET) shares rose 1.56% to $85.95 on Friday, marking the stock's second consecutive day of gains despite a broader market decline where the S&P 500 fell 0.05% and the Dow Jones Industrial Average dropped 0.09%.
The outperformance occurred during an all-around rough trading session for the general stock market, highlighting MetLife's relative strength compared to its peers and the wider index on that specific day.
📈 MetLife shares rose 1.56% to $85.95 on Friday.
📉 Broader market declined with S&P 500 down 0.05%.
🔁 This marks MetLife's second consecutive day of gains.
📈 MetLife Inc. (MET) shares increased by 1.56% to reach a price of $85.95 on Friday.
📉 The broader market declined with the S&P 500 falling 0.05% and the Dow Jones Industrial Average dropping 0.09%.
🔁 This rally represents MetLife's second consecutive day of gains for the stock.
Bullish Signals
MetLife shares gained 1.56%, outperforming declining major indices.
Stock posted second consecutive day of gains.
Bullish Signals
MetLife shares achieved a 1.56% gain, outperforming the broader market which saw declines in major indices like the S&P 500 and Dow Jones.
The stock recorded its second consecutive day of gains, indicating sustained short-term momentum despite negative market conditions.
Zurich Insurance and Farmers Exchanges have officially closed their acquisition of MetLife's U.S. property and casualty business for a total price of $3.94 billion. The transaction involves the purchase of 2.4 million existing Auto & Home policies, which generated $3.6 billion in net written premiums in 2019, along with approximately 3,500 employees.
This strategic move significantly expands Farmers' national footprint, transforming it into a major personal lines carrier available coast-to-coast under the Farmers brand. Jeff Dailey, CEO of Farmers Group, described the deal as a milestone for the company's nearly century-long history, emphasizing that consumers will now have broader choices and opportunities to engage with Farmers for coverage.
The financial structure of the deal saw Zurich contribute $2.43 billion through its Farmers Group Inc unit, while the Farmers Exchanges contributed $1.51 billion. Following the acquisition, MetLife policies will retain their current terms but will be rebranded with the Farmers name. Additionally, a 10-year exclusive distribution agreement was established for Farmers personal lines products on MetLife's Group Benefits platform.
MetLife President and CEO Michel Khalaf stated that divesting this business allows the life insurer to concentrate on its core strengths. The acquisition complements Zurich's existing commercial side operations, which are currently facing a hardening market environment. This deal represents a significant consolidation in the U.S. insurance sector, altering the competitive landscape for personal lines carriers.
🤝 Zurich and Farmers buy MetLife auto/home business for $3.94 billion.
📊 Deal covers 2.4 million policies and $3.6 billion in 2019 premiums.
👥 Approximately 3,500 employees join the combined Farmers organization.
💰 Zurich contributed $2.43B while Farmers contributed $1.51B to total.
🤝 Zurich Insurance and Farmers Exchanges have finalized the purchase of MetLife's U.S. auto and home business for $3.94 billion.
📊 The acquired portfolio includes 2.4 million policies and $3.6 billion in net written premiums recorded in 2019.
👥 Approximately 3,500 employees are being integrated into the combined Farmers organization following the deal closure.
🗺️ The acquisition grants Farmers a nationwide presence, allowing its brand to reach consumers from coast to coast.
💰 Zurich Financial Services contributed $2.43 billion while Farmers Exchanges contributed $1.51 billion to the total transaction value.
🔄 MetLife policies will continue under existing terms but will be rebranded with the Farmers name immediately.
🤝 A 10-year exclusive distribution agreement was signed for Farmers products on MetLife's Group Benefits platform.
🎯 MetLife CEO Michel Khalaf confirmed the sale enables the company to focus resources on its core life insurance strengths.
📈 Jeff Dailey, CEO of Farmers Group, labeled the deal a historic milestone in the company's nearly 100-year history.
🏢 The transaction strengthens Zurich's position as a major player in the U.S. personal lines insurance market.
Bullish Signals
Farmers expands coast-to-coast with immediate national brand recognition.
Deal adds 2.4 million policies and $3.6 billion annual premiums.
Zurich provides deep capital resources for integration support.
10-year exclusive deal reaches 37 million employees on MetLife platform.
Farmers strengthens position in hardening commercial lines environment.
Bullish Signals
Farmers achieves a significant national expansion, transitioning from a regional presence to a coast-to-coast carrier with immediate brand recognition.
The deal provides Farmers with a substantial portfolio of 2.4 million policies and $3.6 billion in annual premiums, instantly boosting revenue scale.
Zurich's involvement brings deep capital resources and operational expertise to support the integration of such a large asset.
Farmers secures a long-term strategic advantage through a 10-year exclusive distribution agreement on MetLife's Group Benefits platform reaching 37 million employees.
The acquisition allows Farmers to strengthen its market position in a hardening commercial lines environment by leveraging the acquired assets.
MetLife successfully divests a non-core asset, allowing management to refocus entirely on its primary life insurance business strengths.
MetLife, Inc. (NYSE: MET) saw increased institutional interest in the fourth quarter of 2025, with Corient Private Wealth LLC raising its stake by 4.4% to own 611,606 shares valued at $48.3 million. Other notable investors including Nordea Investment Management AB, Strs Ohio, and Lansforsakringar Fondforvaltning AB also increased their holdings, while AIA Group Ltd significantly boosted its position by 93.5%. Hedge funds and institutional investors collectively own nearly 95% of the company's outstanding stock.
The stock currently trades with a market capitalization of $55.18 billion and a price-to-earnings ratio of 16.62, supported by a recent quarterly dividend increase to $0.5925 per share, yielding 2.8%. Analyst sentiment remains positive, with major firms like Wells Fargo, Keefe, Bruyette & Woods, and JPMorgan Chase raising their price targets between $95 and $98, while maintaining 'overweight' or 'outperform' ratings.
MetLife operates as a global provider of insurance, annuities, and employee benefit programs with headquarters in New York City. Its core business segments include life insurance, group benefits, retirement products like annuities, and supplemental health coverage such as dental and disability plans distributed through employer-sponsored programs.
💰 Quarterly dividend raised to $0.5925 with a 2.8% yield.
📉 Stock trades at 16.62 P/E ratio and $55.18 billion market cap.
🏦 Analysts raised targets to $95–$98 with a 'Moderate Buy' rating.
🛡️ Core business covers life insurance, annuities, and supplemental health products.
📈 Corient Private Wealth LLC increased its MetLife holdings by 4.4% in Q4 to own 611,606 shares valued at $48.3 million.
📊 Multiple institutional investors including Nordea and Strs Ohio added to their stakes, while AIA Group Ltd nearly doubled its position.
💰 MetLife raised its quarterly dividend to $0.5925 per share, representing a 2.8% yield on the current stock price.
📉 The company trades at a P/E ratio of 16.62 with a market cap of $55.18 billion and a beta of 0.78.
🏦 Major analysts including Wells Fargo, Keefe Bruyette & Woods, and JPMorgan Chase raised price targets to between $95 and $98.
📝 The consensus analyst rating is 'Moderate Buy' with an average target price of $95.31 based on recent research notes.
🛡️ MetLife's core business includes life insurance, annuities, group benefits, and supplemental health products like dental and disability coverage.
Bullish Signals
Institutional investors accumulate shares; AIA Group boosts holdings 93.5%.
Quarterly dividend increased to $0.5925 per share.
Major banks raise price targets between $95 and $98.
Analyst consensus target price is $95.31 with Moderate Buy rating.
Bullish Signals
Institutional investors are accumulating shares, with Corient Private Wealth LLC increasing its stake by 4.4% and AIA Group Ltd boosting holdings by 93.5% in the third quarter.
The company increased its quarterly dividend to $0.5925 per share from the previous $0.57, signaling confidence in cash flow generation.
Multiple major financial institutions including Wells Fargo, Keefe Bruyette & Woods, and JPMorgan Chase raised their price targets to between $95 and $98 with 'overweight' or 'outperform' ratings.
Analyst consensus remains bullish with a 'Moderate Buy' rating and a collective target price of $95.31, suggesting potential upside from current levels.
We use cookies to run the site and, only if you allow it, for live chat, analytics, personalization and ad measurement.
We use cookies to:
Deliver and maintain our services, protect against spam, fraud and abuse
Offer a live chat with our team (Enuchat, optional)
Measure audience engagement and site statistics to understand how our services are used (Google Analytics, optional)
Remember your quiz progress and tailor the knowledge base to your skill level (optional)
Measure how our ads on Facebook and Instagram perform, including whether a visit leads to a confirmed sign-up, matched to your Facebook or Instagram account using hashed contact details you enter (Meta Pixel, optional)
Optional cookies are only set if you allow them. You can accept all, reject all or choose per category, and change your choice at any time via the "Manage Cookies" link in the footer. Google and Meta may process this data in the USA. More in our Privacy Policy.
Manage cookie preferences
Necessary cookiesAlways active
Required for the website to function. These cannot be disabled.
Cookie
Purpose
Duration
PHPSESSID
Session identifier for login, security tokens, and site functionality
Session
cookie_consent
Stores your cookie preferences
1 year
Functional cookies
Show the live chat button so you can message our team. The Enuchat chat widget stores a visitor ID in your browser and sends your chat messages to Enuchat. When this is off, the chat is not loaded.
Cookie
Purpose
Duration
enuchat_visitor_id
Keeps your chat conversation linked to this browser (Enuchat, browser storage)
Until you clear it or turn this off
Analytics cookies
Help us understand how visitors use our website with Google Analytics, provided by Google LLC. Google receives pages visited, device data and an IP address, and may process them in the USA. If you also allow marketing cookies, the Google tag can detect contact details you enter or see on our pages, such as your email address, phone number, name or address, hash them before sending and pass them to Google so it can match your visits to a Google account for measuring our ads. Hashed details are still personal data. See how Google uses information from sites that use its services.
Cookie
Purpose
Duration
_ga
Distinguishes unique visitors (Google Analytics)
2 years
_ga_*
Maintains session state (Google Analytics)
2 years
Personalization cookies
Remember your quiz progress and work out your investing level so we can recommend knowledge-base articles and the right reading depth for you. Stored only on your device.
Cookie
Purpose
Duration
bes_user_level
Your quiz-derived investing level, used to tailor content
1 year
Marketing cookies
Let Meta (Facebook and Instagram) measure how our ads perform, using the Meta Pixel. Meta Platforms Ireland Ltd. receives the pages you visit and, when you confirm the email address of a new account, a "completed registration" event, together with browser identifiers and your IP address. Meta's automatic advanced matching also reads contact details you type into forms on our site, such as your email address or name, hashes them in your browser and sends them with these events so Meta can match them to a Facebook or Instagram account. Hashed details are still personal data. These events are sent from your browser and may also be forwarded to Meta through Meta's Conversions API Gateway. Our own server also sends page visits and completed-registration events directly to Meta's Conversions API, with your IP address, browser user agent and Meta browser identifiers, so Meta can count it once. To help Meta match these visits, your browser and our server also send a random visitor ID from our own cookie and, if you are signed in, your account ID, your confirmed email address and the name, city, postal code and country saved in your profile, all hashed first. We and Meta are joint controllers for collecting and sending this data, and Meta's further use, which may include processing in the USA, is described in the Meta Privacy Policy. When this is off, the Meta Pixel is not loaded and no page visit or registration event is sent to Meta. Together with analytics cookies, this choice also lets Google receive hashed contact details, as described under Analytics cookies.
Cookie
Purpose
Duration
_fbp
Identifies browsers for Meta ad measurement (Meta Pixel)
3 months
_fbc
Stores the Meta ad click that brought you here (Meta Pixel)
3 months
_bes_meid
Random visitor ID, sent to Meta only hashed, so your visits can be matched (Meta Pixel and Conversions API)